Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | FGFR2 |
| Variant | Q621L |
| Impact List | missense |
| Protein Effect | unknown |
| Gene Variant Descriptions | FGFR2 Q621L (corresponds to Q620L in the canonical isoform) lies within the protein kinase domain of the Fgfr2 protein (UniProt.org). Q621L has been identified in sequencing studies (PMID: 39706336), but has not been biochemically characterized and therefore, its effect on Fgfr2 protein function is unknown (PubMed, Jul 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
FGFR2 mutant FGFR2 Q621L |
| Transcript | NM_022970.4 |
| gDNA | chr10:g.121496536T>A |
| cDNA | c.1862A>T |
| Protein | p.Q621L |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_022970.4 | chr10:g.121496536T>A | c.1862A>T | p.Q621L | RefSeq | GRCh38/hg38 |
| NM_001144913.1 | chr10:g.121496536T>A | c.1862A>T | p.Q621L | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|